- Pioneering Tomorrow's Therapeutics -
NCP has been an early pioneer in material science applications in microgravity with science and hardware development support services related to macromolecular crystal growth. Historically, our company and experience has included a highly successful series of multi-user payloads flown under contract though NASA on the Space Shuttle, the Russian Mir Space Station, and the International Space Station.Learn More
NCP's self-assembling ferritin nano particles are currently transforming the development of new vaccines.Learn More
Dr. Carter has served as the President and CEO of New Century Pharmaceuticals since 1997. With a passion for science in the public interest, Dr. Carter maintains an active role in research with extensive experience in molecular structural biology, protein engineering, protein production and related microgravity applications.
As the principal protein of the circulatory system, albumin is a major effector of drug pharmacokinetics. Albumin sequestration of drugs often renders them less effective requiring higher dosing with increased cytotoxicity.Read More
As the principal protein of the circulatory system, albumin is a major pharmacokinetic effector of pharmaceuticals, playing an important role in therapeutic bioavailability and half-life.Read More